Baltimore’s biotech community is facing a major shakeup as Catalent, a leading pharmaceutical manufacturer, is set to lay off 350 employees across three local facilities. Most of these job losses will hit Harmans in Anne Arundel County, with others at the University of Maryland BioPark. For many families and workers in the area, this means big changes ahead. With Catalent’s global reach and recent billion-dollar acquisitions, what does this mean for the future of Maryland’s life sciences industry? Let’s talk about how these changes could impact our local economy and community. #Business #Baltimore #Biotech